
NeuroForge
NOOTROPIC / NEUROPEPTIDE
Heptapeptide ACTH(4–7) analog originally developed in Russia. Engineered around BDNF upregulation and dopaminergic signalling for cognitive-research and neuro-resilience protocols.
Protocol
Reconstitute with 2 mL of bacteriostatic water. Typical research cadence: 300–600 mcg intranasally, one to three times daily. Store reconstituted vial refrigerated; use within thirty days. Rotate injection sites. Research use only until supplied with an applicable prescription.
60 in stock